Bimatoprost is a mixed inhibitor of the aldo-keto reductase 1C3 (AKR1C3) enzyme: A potential treatment target for sex hormone-dependent diseases.

KM Marshall, OH Zarroug, DP Fischer, Anna Nicolaou, K Watanabe, DF Woodward

Research output: Contribution to conferencePosterpeer-review

Original languageEnglish
Publication statusPublished - Dec 2015
EventBritish Pharmacol Society, - London
Duration: 15 Dec 201517 Dec 2015


ConferenceBritish Pharmacol Society,

Cite this